drugset / Trial / NCT05103098
Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2022-12-31
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 400 ug | — |
| Subject | Misoprostol | Other / unclassified | 800 ug | — |